1. Identification of Reduced Host Transcriptomic Signatures for Tuberculosis Disease and Digital PCR-Based Validation and Quantification.
- Author
-
Gliddon HD, Kaforou M, Alikian M, Habgood-Coote D, Zhou C, Oni T, Anderson ST, Brent AJ, Crampin AC, Eley B, Heyderman R, Kern F, Langford PR, Ottenhoff THM, Hibberd ML, French N, Wright VJ, Dockrell HM, Coin LJ, Wilkinson RJ, and Levin M
- Subjects
- Adult, Aged, Biomarkers blood, Carrier Proteins genetics, Diagnostic Tests, Routine, Female, Gene Expression Profiling, Humans, Male, Middle Aged, Mitochondrial Proteins genetics, Mycobacterium tuberculosis genetics, Protein Array Analysis, RNA, Messenger blood, RNA, Messenger genetics, Receptors, IgG genetics, Reverse Transcriptase Polymerase Chain Reaction, South Africa, Young Adult, Carrier Proteins blood, Latent Tuberculosis diagnosis, Mitochondrial Proteins blood, Receptors, IgG blood, Transcriptome genetics, Tuberculosis, Pulmonary diagnosis, Zinc Fingers physiology
- Abstract
Recently, host whole blood gene expression signatures have been identified for diagnosis of tuberculosis (TB). Absolute quantification of the concentrations of signature transcripts in blood have not been reported, but would facilitate diagnostic test development. To identify minimal transcript signatures, we applied a transcript selection procedure to microarray data from African adults comprising 536 patients with TB, other diseases (OD) and latent TB (LTBI), divided into training and test sets. Signatures were further investigated using reverse transcriptase (RT)-digital PCR (dPCR). A four-transcript signature ( GBP6, TMCC1, PRDM1 , and ARG1 ) measured using RT-dPCR distinguished TB patients from those with OD (area under the curve (AUC) 93.8% (CI
95% 82.2-100%). A three-transcript signature ( FCGR1A, ZNF296, and C1QB ) differentiated TB from LTBI (AUC 97.3%, CI95% : 93.3-100%), regardless of HIV. These signatures have been validated across platforms and across samples offering strong, quantitative support for their use as diagnostic biomarkers for TB., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Gliddon, Kaforou, Alikian, Habgood-Coote, Zhou, Oni, Anderson, Brent, Crampin, Eley, Heyderman, Kern, Langford, Ottenhoff, Hibberd, French, Wright, Dockrell, Coin, Wilkinson and Levin.)- Published
- 2021
- Full Text
- View/download PDF